Table 1.

Comparison of patients referred and not referred for medical and surgical weight-loss interventions

CHARACTERISTICSTOTAL ELIGIBLE, N (%) (N = 15 526)REFERRALχ2 TEST P VALUE
NO, N (%) (n = 14 560)YES, N (%) (n = 966)
Age, y< .0001
    • 18-291284 (8.3)1189 (8.2)95 (9.8)
    • 30-391876 (12.1)1673 (11.5)203 (21.0)
    • 40-493031 (19.5)2747 (18.9)284 (29.4)
    • 50-593888 (25.0)3614 (24.8)274 (29.4)
    • 60-693461 (22.3)3357 (23.1)104 (10.8)
    • ≥ 701986 (12.8)1980 (13.3)6 (0.62)
Sex, % male6292 (40.5)6074 (41.7)218 (22.6)< .0001
Average (SD) BMI, kg/m245.6 (19.8)45.5 (20.1)48.2 (12.7)< .0001
Location< .0001
    • Rural4820 (31.0)4465 (30.7)355 (36.7)
    • Urban10 706 (69.0)10 095 (69.3)611 (63.2)
Hypertension7474 (48.1)7082 (48.6)345 (35.7)< .0001
Osteoarthritis4475 (28.8)4221 (29.0)254 (26.3).0732
Diabetes5494 (35.4)5149 (35.4)345 (35.7).8255
HbA1c level, %.3241
    • ≤ 7.02483 (47.0)2335 (47.0)148 (47.4)
    • 7.1-9.02169 (41.1)2055 (41.4)114 (36.7)
    • > 9.0629 (11.9)579 (11.6)50 (16.0)
Dyslipidemia9843 (63.4)9302 (63.9)541 (56.0)< .0001
BMI, kg/m2< .0001
    • 35-39.97192 (46.3)7022 (48.2)170 (17.6)
    • 40.0-44.94029 (25.9)3765 (25.9)264 (27.3)
    • 45.0-49.91854 (11.9)1627 (11.1)230 (23.8)
    • ≥ 50.02451 (15.8)2149 (14.8)302 (31.3)
Antihypertensive prescription*303 (1.9)288 (2.0)15 (1.5).3549
Antidiabetic prescription*4299 (27.7)4015 (27.6)284 (29.4).2199
  • BMI—body mass index, HbA1c—hemoglobin A1c.

  • * At least 1 prescription.